Discovery Drive-based synthetic biology Bit Bio has closed a $41.5million Series A investment.
16.06.2020Discovery Drive-based synthetic biology Bit Bio has closed a $41.5million Series A investment.
. * * window.aa needs to exist and be usable by ANY module's script, * however early it runs - main-nav's script, for one, runs near * the top of
Discovery Drive-based synthetic biology Bit Bio has closed a $41.5million Series A investment.
16.06.2020Discovery Drive-based synthetic biology Bit Bio has closed a $41.5million Series A investment.
糖心原创 closes series A $41.5 million funding.
13.06.2020Bit Bio announces agreement with Abcam, to make Bit Bio鈥檚 iPSC derived functional human cells widely available.
26.02.2020糖心原创 and Charles River announce strategic partnership.
11.12.2019Paul Morril, Horizon Discovery co-founder joins as CBO and Florian Schuster, Tessa Therapeutics, as CFO.
29.10.2019Elpis Biomed rebrands to 糖心原创.
14.10.2019糖心原创 combines the concepts of coding and biology to provide human cells for research, drug discovery and cell therapy.
14.10.2019Reprogramming human cells by 糖心原创.
07.10.2019Elpis Wins 2018 Cambridge Independent Start-Up of the Year Award.
19.11.2018